In order to provide novel insights into the FGF2 regulation by estrogens within the tumor microenvironment, we sought to address whether estrogens may regulate FGF2 levels in ER-negative/ GPER-positive CAFs isolated from breast tumor patients (see material and methods section). Here, GPER1 is linked to breast neoplasm.